Compare PEBO & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PEBO | TNDM |
|---|---|---|
| Founded | 1902 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.5B |
| IPO Year | N/A | 2013 |
| Metric | PEBO | TNDM |
|---|---|---|
| Price | $31.57 | $21.97 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 16 |
| Target Price | ★ $34.58 | $22.44 |
| AVG Volume (30 Days) | 156.5K | ★ 2.3M |
| Earning Date | 01-20-2026 | 11-06-2025 |
| Dividend Yield | ★ 5.22% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.86 | N/A |
| Revenue | $555,347,000.00 | ★ $1,007,001,000.00 |
| Revenue This Year | N/A | $8.59 |
| Revenue Next Year | $3.07 | $10.19 |
| P/E Ratio | $10.99 | ★ N/A |
| Revenue Growth | 10.92 | ★ 17.87 |
| 52 Week Low | $26.21 | $9.98 |
| 52 Week High | $35.12 | $38.28 |
| Indicator | PEBO | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 68.75 | 66.05 |
| Support Level | $30.14 | $20.27 |
| Resistance Level | $31.53 | $22.10 |
| Average True Range (ATR) | 0.51 | 1.12 |
| MACD | 0.19 | -0.08 |
| Stochastic Oscillator | 89.20 | 91.59 |
Peoples Bancorp Inc (Marietta OH) is a financial holding company. As a community bank, it offers a complete line of banking, insurance, investment, and trust solutions through its financial subsidiaries. It offers demand deposit accounts, savings accounts, real estate mortgage loans, merchant credit card transaction processing services, corporate and personal trust services, life, health, property, and casualty insurance products, and brokerage services. The bank also offers telephone and internet-based banking through both personal computers and mobile devices.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.